All Companies

JNJ

Johnson & Johnson

Pharmaceutical Preparations

$269.99updated Sep 19, 2026

Congressional trading profile for Johnson & Johnson (JNJ), covering 53 disclosed transactions by 21 lawmakers.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Total Trades

53

Politicians Trading

21

Last Traded

Aug 27, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Thomas H. Kean, Jr.RSep 12, 2026Aug 27, 2026Sell$1,001 - $15,000+1.59%
Richard McCormickRAug 14, 2026Jul 30, 2026Sell$1,001 - $15,000+5.54%
Thomas H. Kean, Jr.RJul 15, 2026Jun 29, 2026Sell$1,001 - $15,000+4.44%
Thomas H. Kean, Jr.RJul 15, 2026Jun 2, 2026Sell$1,001 - $15,000+21.13%
Thomas H. Kean, Jr.RFeb 19, 2026Jan 23, 2026Sell$15,001 - $50,000+22.64%
Thomas H. Kean, Jr.RDec 19, 2025Nov 20, 2025Sell$15,001 - $50,000+32.95%
Lisa C. McClainRNov 21, 2025Oct 31, 2025Sell$1,001 - $15,000+42.95%
Lisa C. McClainRNov 21, 2025Oct 30, 2025Sell$1,001 - $15,000+42.81%
Sheri BiggsROct 5, 2025Mar 19, 2025Sell$15,001 - $50,000+65.65%
Thomas H. Kean, Jr.RAug 20, 2025Jul 31, 2025Sell$15,001 - $50,000+63.89%
Lisa C. McClainRAug 13, 2025Jun 24, 2025Sell$1,001 - $15,000+77.40%
Scott FranklinRJul 14, 2025Jun 16, 2025Sell$15,001 - $50,000+73.94%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$50,001 - $100,000+75.16%
Pete SessionsRJun 21, 2025Jun 12, 2025Sell$15,001 - $50,000+72.34%
Bruce WestermanRMay 12, 2025Apr 21, 2025Sell$1,001 - $15,000+72.06%
Robert BresnahanRApr 28, 2025Apr 8, 2025Sell$1,001 - $15,000+79.99%